3-Year study tests Real-World impact of HAE prevention drug
NCT ID NCT04130191
Summary
This study followed 140 people with hereditary angioedema (HAE) for up to three years to see how well the drug lanadelumab worked in everyday life. The main goal was to compare the number of HAE attacks people had while on the drug to the number they had before starting it. Participants tracked their symptoms and quality of life using a smartphone app and during regular doctor visits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco
Milan, 20157, Italy
-
Al-Rashed Allergy Center
Kuwait City, 90806, Kuwait
-
Azienda Ospedale Università Padova
Padua, 35128, Italy
-
Azienda Ospedaliera Universitaria Federico II
Naples, Campania, 80131, Italy
-
Bnai Zion Medical Center
Haifa, 31048, Israel
-
Charité - Universitätsmedizin Berlin
Berlin, 10117, Germany
-
Hospital Universitario Vall d'Hebron - PPDS
Barcelona, 08035, Spain
-
Hospital Universitario de Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Hämophilie Zentrum Rhein Main GmbH
Mörfelden-Walldorf, 64546, Germany
-
Klinikum der Johann-Wolfgang Goethe-Universitat
Frankfurt am Main, Hesse, 60590, Germany
-
Klinikum rechts der Isar der Technischen Universität München
München, 81675, Germany
-
Luzerner Kantonsspital LUKS
Lucerne, 6000, Switzerland
-
Medical University of Vienna
Vienna, 1090, Austria
-
Sheba Medical Center - PPDS
Ramat Gan, 52621, Israel
-
Universitatsklinikum Dusseldorf
Düsseldorf, 40225, Germany
-
Universitatsklinikum Schleswig-Holstein
Lübeck, 23538, Germany
-
Universitätsklinikum Münster
Münster, 48149, Germany
-
Universitätsklinikum Ulm
Ulm, 89075, Germany
-
Universitätsspital Basel
Basel, 4031, Switzerland
Conditions
Explore the condition pages connected to this study.